Carnitine deficiency-induced cardiomyopathy

Molecular and Cellular Biochemistry

Volumn 180, Issue 1-2, 1998, Pages 33-41

  Paulson, Dennis J ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Acyl carnitine derivitives; Long chain fatty acids; Mitochondrial metabolism

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARNITINE;

CARDIOMYOPATHY; CARNITINE DEFICIENCY; HEART MUSCLE CONTRACTILITY; HUMAN; REVIEW;

ANIMALS; CARDIOMYOPATHIES; CARNITINE; DISEASE MODELS, ANIMAL; HUMANS; KINETICS; MODELS, BIOLOGICAL; VITAMIN B DEFICIENCY;

ANIMALIA;

EID: 0031884872     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006826620218     Document Type: Review

References (81)

1. Bremer J: Carnitine-metabolism and functions. Physiol Rev 63: 1421-1480, 1983
2. Neely JR, Morgan HA: Relationship between carbohydrate metabolism and energy balance of heart muscle. Ann Rev Physiol 36: 413-459, 1974
3. Bieber LL, Emaus R, Valkner K, Farrell S: Possible functions of short- chain and medium-chain carnitine acyltransferases. Fed Proc 41: 2858- 2862, 1982
4. Stanley WC, Lopaschuk GD, Hall JC, McCormack JG: Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions - Potential for pharmacological interventions. Cardiovasc Res 33: 243-257, 1997
5. Broderick TL, Quinney HA, Barker CC, Lopaschuk GD: Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circ 87: 972-981, 1993
6. Rebouche CJ, Paulson DJ: Carnitine metabolism and functions in humans. Ann Rev Nutr 6: 41-66, 1986
7. Tripp ME, Katcher ML, Peters HA, Gilbert EF, Hodach RJ, Shug AL: Systemic carnitine deficiency presenting as familial endocardial fibroelastosis. N Engl J Med 305: 385-390, 1981
8. Waber LJ, Valle D, Neill C, Di Mauro S, Shug A: Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transport. J Pediat 101: 700-705, 1982
9. Christensen E, Vikre-Jorgensen J: Six years experience with carnitine supplementation in a patient with an inherited defective carnitine transport system. J Inherit Metab Dis 18: 233-236, 1995
10. Long CS, Haller RG, Foster DW, McGarry JD: Kinetics of carnitine dependent fatty acid oxidation: Implication for human carnitine deficiency. Neurology 32: 663-666, 1982
11. Bieber LL: Carnitine. Ann Rev Biochem 57: 261-283, 1988
12. Van Hinsbergh VWM, Veerkamp JH, Van Moerkerk HTh: Palmitate oxidation by rat skeletal muscle mitochondria. Comparison of polarographic and radiochemical experiments. Arch Biochem Biophys 190: 762-771, 1978
13. Weis BC, Esser V, Foster DW, McGarry JD: Rat heart expresses two forms of mitochondrial carnitine palmitoyltransferase I. The minor component is identical to the liver enzyme. J Biol Chem 269: 18712-18715, 1994
14. Xia Y, Buja LM, McMillin JB: Change in expression of heart carnitine palmitoyltransferase I isoforms with electrical stimulation of cultured rat neonatal cardiac myocytes. J Biol Chem 271: 12082-12087, 1996
15. Weis BC, Cowan AT, Brown N, Foster DW, McGarry JD: Use of a selective inhibitor of liver carnitine palmitoyltransferase I (CPT I) allows quantification of its contribution to total CPT I activity in rat heart. Evidence that the dominant cardiac CPT I isoform is identical to the skeletal muscle enzyme. J Biol Chem 269: 26443-26448, 1994
16. Paulson DJ, Shug AL: Inhibition of the adenine nucleotide translocator by matrix-localized palmityl-CoA in rat heart mitochondria. Biochim Biophys Acta 766: 70-76, 1984
17. +-ATPase by palmitylcarnitine and palmityl-CoA. Biochem Biophys Res Commun 74: 677-684, 1977
18. Clarke SD, Abraham S: Gene expression: Nutrient control of pre- and posttranscriptional events. FASEB J 6: 3146-3152 1992
19. Dillman WH: Diabetes mellitus induces changes in cardiac myosin of the rat. Diabetes 29: 579-582, 1980
20. Rupp H, Elimban V, Dhalla NS: Modification of subcellular organelles in pressure overloaded heart by etomoxir, a carnitine palmitoyl- transferase I inhibitor. FASEB J6: 2349-2353, 1992
21. Rupp H, Wahl R, Hansen M: Influence of diet and carnitine palmitoyl- transferase I inhibition on myosin and sarcoplasmic reticulum. J Appl Physiol 72: 352-360, 1992
22. Sugden MC, Holness MJ: Interactive regulation of the pyruvate dehydrogenase complex and the carnitine palmitoyltransferase system. FASEB J 8: 54-61, 1994
23. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP: The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91: 11012- 11016, 1994
24. Kelly DP, Strauss AW: Inherited cardiomyopathies. N Engl J Med 330: 913-919, 1993
25. Sack MN, Rader TA, Park S, Bastin J, McCone SA, Kelly DP: Fatty acid oxidation enzymes gene expression is downregulated in the failing heart. Circ 94: 2837-2842, 1996
26. Breningstall GN: Carnitine deficiency syndromes. Ped Neurol 6: 75- 81, 1990
27. DeVivo DC, Tein I: Primary and secondary disorders of carnitine metabolism. Int Fed 5: 134-141, 1990
28. Rebouche CJ, Engel AG: Carnitine metabolism and deficiency syndromes. Mayo Clin Proc 58: 533-540, 1983
29. Tanphaichitr V, Leelehagul P: Carnitine metabolism and human carnitine deficiency. Nutrition 9: 246-254, 1993
30. Angelini C, Vergani L, Martinuzzi A: Clinical and biochemical aspects of carnitine deficiency and insufficiency: transport defects and inborn errors of b-oxidation. Crit Rev Clin Lab Sci 29: 217-242, 1992
31. Famularo G, De Simone C: A new era for carnitine. Immunol Today 16: 211-213, 1995
32. Christensen E: Cardiomyopathy and abnormal carnitine metabolism. J Pediatr 114: 903, 1989
33. Schölte HR, Rodrigures Pereira R, de Jonge PC, Luyt-Houwin IE, Hedwig M, Verduin M, Ross JD: Primary carnitine deficiency. J Clin Chem Clin Biochem 28: 351-357, 1990
34. Stanley CA: Carnitine disorders. Adv Pediatr 42: 209-242, 1995
35. Vikre-Jorgensen J: Cardiomyopathy caused by carnitine deficiency. Ugeskrift for Laeger 155: 3390-3392, 1993
36. Bennett MJ, Hale DE, Pollitt RJ, Stanley CA, Variend S: Endocardial fibroelastosis and primary carnitine deficiency due to a defect in the plasma membrane carnitine transport [clinical conference]. Clin Cardiol 19: 243-246, 1996
37. Zales VR, Benson DW Jr: Reversible cardiomyopathy due to carnitine deficiency from renal tubular wasting. Pediat Cardiol 16: 288-292, 1995
38. Duran M, Loof NE, Ketting D, Dorland L: Secondary carnitine deficiency. J Clin Chem Clin Biochem 28: 359-363, 1990
39. Stanley CA, Berry GT, Bennett MJ, Willi SM, Treem WR, Hale DE: Renal handling of carnitine in secondary carnitine deficiency disorders. Pediatr Res 34: 89-97, 1993
40. Chalmers RA, Roe CR, Stacey TE, Hoppel CL: Urinary eccretionof 1- carnitine and acylcarnitine by patients with disorder of organic acid metabolism: evidence for secondary insufficiency of L-carnitine. Ped Res 18: 1325-1328, 1984
41. Roe CR, Millington DS, Maltby DA, Kahler SG, Bohan TP: L-carnitine therapy in isovaleric acidemia. J Clin Invest 74: 2290-2295, 1984
42. Shapira Y, Gutman A: Muscle carnitine deficiency in patients using valproic acid. J Pediatr 118: 646-649, 1991
43. Kurczynski TW, Hoppel CL, Goldblatt PJ, Gunning WT: Metabolic studies of carnitine in a child with propionic acidemia. Pediatr Res 26: 63-66, 1989
44. Roe CR, Millington DS, Maltby DA, Bohan TP, Hoppel CL: L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. J Clin Invest 1993
45. Chalmers RA, Stacey TE, Tracey BM, De Souse C, Roe CR, Millington DS, Hoppel CL: L-carnitine insufficiency in disorders of organic acid metabolism: Response to L-carnitine by patients with methylmalonic aciduria and 3-hydroxy-3-methylglutaric aciduria. J Inher Metab Dis 7(Suppl 2): 109-110, 1984
46. Ohtani Y, Nishiyama S, Matsuda I : Renal handling of free and acylcarnitine in secondary carnitine deficiency. Neurology 34: 977- 999, 1984
47. Gahl WA, Bernardini IM, Dalakas MC, Markello TC, Krasnewich DM, Charnas LR: Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis. Pediatr Res 34: 115-119, 1993
48. Heinonen OJ, Takala J: Carnitine status during prolonged total parenteral nutrition. J Pediatr 122: 503, 1993
49. Heinonen OJ, Takala J, Kvist M: Effect of food restriction on tissue carnitine concentration in rats. Clin Nutr 10: 85-90, 1991
50. Ahmad S, Dasgupta A, Kenny MA: Fatty acid abnormalities in hemodialysis patients: Effect of L-carnitine administration. Kidney Int 36 (Suppl 27): S243-S246, 1989
51. Ahmad S, Robertson HT, Golper TA, Wolfson M, Kurtin P, Katz LA, Hirschberg R, Nicora R, Ashbrook DW, Kopple JD: Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int 38: 912-918, 1990
52. Lanza-Jacoby S, Reibel DK: Changes in tissue levels of carnitine during E. coli sepsis in the rat. Circ Shock 24: 29-34, 1988
53. Regitz V, Bossaller C, Strasser R, Müller M, Shug AL, Fleck E: Metabolic alterations in end-stage and less severe heart failure - Myocardial carnitine decrease. I Clin Chem Clin Biochem 28: 611-617, 1990
54. Wennberg A, Hyltander A, Sjöberg Å, Arfvidsson B, Sandström R, Wickström I, Lundholm K: Prevalence of carnitine depletion in critically ill patients with undernutrition. Metabolism 41: 165-171, 1992
55. Paulson DJ, Sanjak M, Shug AL: Carnitine deficiency and the diabetic heart. In: Carter AL (ed). Current Concepts in Carnitine Research. CRC Press, Boca Raton, Florida, 1992, pp 215-230
56. Castro-Gago M, Camina F, Rodriguez-Segade S: Carnitine deficiency caused by valproic acid. J Pediatr 120: 496, 1992
57. Murakami K, Sugimoto T, Nishida N, Kobayashi Y, Kuhara T, Matsumoto I: Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during chronic valproate therapy. Brain Dev 14: 178-181, 1992
58. Opala G, Winter S, Vance C, Vance H, Hutchison HT, Linn LS: The effect of valproic acid on plasma carnitine levels. Am J Dis Child 145: 999-1001, 1991
59. Kossak BD, Schmidt-Sommerfeld E, Schoeller DA, Rinaldo P, Penn D, Tonsgard JH: Impaired fatty acid oxidation in children on valproic acid and the effect of L-carnitine. Neurology 43: 2362-2368, 1993
60. Holme E, Jodal U, Linstedt S, Nordin I: Effects of pivalic acid-containing prodrugs on carnitine homeostasis and on response to fasting in children. Scand J Clin Lab Invest 52: 361-372, 1992
61. Rose SJ, Stokes TC, Patel S, Cooper MB, Betteridge D, Payne JE: Carnitine deficiency associated with long-term pivampicillin treatment: The effect of a replacement therapy regime. Postgrad Med J 68: 932-934, 1992
62. Abrahamsson K, Eriksson BO, Holme E, Jodal U, Lindstedt S, Nordin I: Impaired ketogenesis in carnitine depletion caused by short-term administration of pivalic acid prodrug. Biochem Med Metab Biol 52: 18-21, 1994
63. Winter SC: Clinical approach to altered metabolism of fatty acid metabolism in the pediatric practice. Discovery International ZT 29101989
64. Paulson DJ, Shug AL: Tissue specific depletion of L-carnitine in rat heart and skeletal muscle by D-carnitine. Life Sci 28: 2931-2938, 1981
65. Bianchi PB, Davis AT: Sodium pivalate treatment reduces tissue carnitines and enhances ketosis in rats. J Nutr 121: 2029-2036, 1991
66. Diep QN, Bohmer T, Skrede S: Formation of pivaloylcarnitine in heart and brown adipose tissue in the rat. Biochim Biophys Acta Gen Subj 1243: 65-70, 1995
67. El Alaoui-Talibi Z, Landormy S, Loireau A, Moravec J: Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts. Am J Physiol Heart Circ Physiol 262: H1068-H1074, 1992
68. Whitmer JT: L-carnitine treatment improves cardiac performance and restores high energy phosphate pools in cardiomyopathic Syrian hamster. Circ Res 61: 396-408, 1987
69. Tsoko M, Beauseigneur F, Gresti J, Niot I, Demarquoy J, Boichot J, Bezard J, Rochelte L, Clovet P: Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of L-carnitine by D- carnitine and a gamma-butyrobetaine hydroxylase inhibitor. Biochem Pharmacol 49: 1403-1410, 1995
70. Keene BW, Panciera DP, Atkins CE, Regitz V, Schmidt MJ, Shug AL: Myocardial L-carnitine deficiency in a family of dogs with dilated cardiomyopathy. J Am Vet Med Assoc 198: 647-650, 1991
71. Horiuchi M, Yoshida H, Kobayashi K, Kuriwaki K, Yoshimine K, Tomomura M, Koizumi T, Nikaido H, Hayakawa J, Kuwajima M, Saheki T: Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett 326: 267-271, 1993
72. Miyagawa J, Kuwajima M, Hanafiusa T, Ozaki K, Fujimura H, Ono A, Venaka R, Narama I, Ove T, Yamamoto K: Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency. Virchows Archiv 426: 271-279, 1995
73. Uenaka R, Kuwajima M, Ono A, Matsuzawa Y, Hagakawa J, Inohara N, Kagawa Y, Ohta S: Increased expression of carnitine palmityoyl- transferase I gene is repressed by administration of L-carnitine in the hearts of carnitine-deficient juvenile visceral steatosis mice. J Biochem 119: 533-540, 1996
74. Heinonen OJ, Takala J: Experimental carnitine depletion in rats. Clin Nutr 10: 91-96, 1991
75. Heinonen OJ, Takala J: Moderate carnitine depletion and long-chain fatty acid oxidation, exercise capacity, and nitrogen balance in the rat. Pediatr Res 36: 288-292, 1994
76. Morris OS, Zhou Q, Wolf SC, DiDomenico DF, Shug AL, Paulson DJ: Sodium pivalate reduces cardiac carnitine content and increases glucose oxidation without affecting cardiac functional capacity. Life Sci 57: 2237-2244, 1995
77. Broderick TL, Christos SC, Wolf BA, DiDomenico D, Shug AL, Paulson DJ: Fatty acid oxidation and cardiac function in the sodium pivalate model of secondary carnitine deficiency. Metabolism 44: 499-505, 1995
78. Broderick TL, DiDomenico D, Shug AL, Paulson DJ: L-propionylcarnitine effects on cardiac carnitine content and function in secondary carnitine deficiency. Can J Physiol Pharmacol 73: 509-514, 1995
79. Broderick TL, Panagakis G, DiDomenico D, Gamble J, Lopaschuk GD, Shug AL, Paulson DJ: L-Carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts. Cardiovasc Res 30: 815-820, 1995
80. Holme E, Jacobson CE, Nordin I: Carnitine deficiency induced by pivampicillin and pivmecillinam therpy. Lancet 2: 469-472, 1989
81. Abrahamsson K, Mellander M, Eriksson BO, Holme E, Jodal V, Jönsson A, Lindstedt S: Transient reduction of human left ventricular mass in carnitine depletion induced by antibiotics containing pivalic acid. Br Heart J 74: 656-659, 1995